• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, September 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

New exercise guidelines for people with cancer

Bioengineer by Bioengineer
May 23, 2019
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A decade-old treatment recommendation for people with cancer to take a “slowly slowly” approach to exercise has been replaced with new guidelines recommending a personalised exercise program including high-intensity workouts to achieve the best treatment outcome.

Led by QUT Research Fellow Professor Sandi Hayes, researchers from QUT and Edith Cowan University (ECU) have just published the Exercise and Sports Science Australia’s (ESSA) Position Statement on Exercise Medicine in Cancer Management in the Journal of Science and Medicine in Sport.

Professor Hayes said ten years ago, in the ESSA’s first position statement on the topic, the best advice for people with cancer was to follow a generic exercise program of low to moderate intensity, with three to five sessions per week including aerobic, resistance or a mixture of both.

But in the past decade evidence has challenged that advice.

Professor Hayes said the research that had emerged since the release of the first position statement demonstrated the benefit to cancer outcomes _ including specific treatment-related side effects, such as lymphoedema and fatigue _ which could be achieved with a targeted approach to exercise prescription.

One of the key changes in the new recommendations is that the guidelines no longer have a generic exercise program recommendation of a specified number of workouts a week.

“Research in this space has exponentially grown and consequently, the updated position stand now provides the foundation for Accredited Exercise Physiologists to ensure their exercise prescription is targeted towards improving cancer outcomes,” Professor Hayes said.

“While for the majority of cancer patients, moderate to high intensity exercise will likely be appropriate, there is no set prescription and total weekly dosage that would be considered evidence-based for all cancer patients.”

“Precision medicine is about optimising patient outcomes. This position statement allows for precision medicine through exercise.”

Director of ECU’s Exercise Medicine Research Institute and co-author of the statement Professor Daniel Galvão said: “No one cancer patient is the same as another. Therefore, there is no ‘one size fits all’ exercise prescription.”

“The type, duration, frequency, intensity and total volume of exercise prescription needs to be tailored to the patient’s needs and priorities,” Professor Galvão said.

“This position statement uses evidence, alongside best practice, to determine who needs what type, intensity, frequency and duration of exercise and when.

“For example, for patients with a low level of fitness, or those with advanced stage disease, a starting exercise prescription may need to involve multiple short bouts of five to ten minutes, to accumulate at least 20 minutes on any given day.

“As exercise capacity improves, progression towards longer sessions of at least 20 minutes duration on most days of the week is recommended.”

###

Media contact:

Rod Chester, QUT Media, 07 3138 9449, [email protected]

After hours: Rose Trapnell, 0407 585 901, [email protected]

Media Contact
Rod Chester
[email protected]

Related Journal Article

https://www.qut.edu.au/news?id=144691
http://dx.doi.org/10.1016/j.jsams.2019.05.003

Tags: cancerMedicine/Health
Share12Tweet7Share2ShareShareShare1

Related Posts

FBXW11 Ubiquitinates YB1, Suppressing Hepatocarcinoma Growth

September 13, 2025

Advancing Liver Transplantation for Cancer with Genomics

September 13, 2025

Tumor Microenvironment Dynamics in Breast Cancer Therapy

September 13, 2025

Blocking Tumors: PD-L1 siRNA Boosts Immunotherapy

September 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    66 shares
    Share 26 Tweet 17
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Impact of Electrode Material on Radish Germination

Maize Fungal Diseases: Pathogen Diversity in Ethiopia

Unraveling Gut Microbiota’s Role in Breast Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.